CCL2 and neoplasm: Analysis of tumor-infiltrated lymphocytes revealed that KD of Hk2 or inhibiting CCL2 signaling in KPC tumors reduced monocyte/macrophage infiltration but enhanced T cell infiltration and function (Supplemental Figure 4B).